“Risk of hepatitis B reactivation in rheumatic patients receiving tocilizumab treatment”, Ann Med Res , vol. 32, no. 11, pp. 512–517, Nov. 2025, Accessed: Dec. 02, 2025. [Online]. Available: http://www.annalsmedres.org/index.php/aomr/article/view/4880